• 1. Evolutionary approaches in protein engineering towards biomaterial construction
  Brindha J.,Balamurali M. M.,Kaushik Chanda RSC Adv., 2019,9, 34720-34734
• 2. Dissociative electron attachment to HGaF4 Lewis–Br?nsted superacid
  Marcin Czapla,Jack Simons Phys. Chem. Chem. Phys., 2018,20, 21739-21745
• 3. Evolution study of photo-synthesized gold nanoparticles by spectral deconvolution model: a quantitative approach
  Chung-Sung Yang,Mong-Shian Shih,Fang-Yi Chang New J. Chem., 2006,30, 729-735
• 4. Embedding heteroatoms: an effective approach to create porphyrin-based functional materials
  Norihito Fukui,Keisuke Fujimoto,Hideki Yorimitsu,Atsuhiro Osuka Dalton Trans., 2017,46, 13322-13341
• 5. Fate of nitrogen-15 in the subsequent growing season of greenhouse tomato plants (Lycopersicon esculentum Mill) as influenced by alternate partial root-zone irrigation
  Maomao Hou,Fenglin Zhong,Qiu Jin,Enjiang Liu,Jie Feng,Tengyun Wang,Yue Gao RSC Adv., 2017,7, 34392-34400

• Solvents and Organic Chemicals Organic Compounds Organohalogen compounds Aryl halides Aryl chlorides

3-(4-Chloro-1H-pyrazol-1-yl)propanoic acid: A Comprehensive Overview

3-(4-Chloro-1H-pyrazol-1-yl)propanoic acid, identified by the CAS registry number 913839-78-8, is a compound of significant interest in the fields of organic chemistry and pharmacology. This compound, with its unique structure and properties, has garnered attention due to its potential applications in drug development and material science. In this article, we delve into the structural characteristics, synthesis methods, biological activities, and recent advancements associated with this compound.

The molecular structure of 3-(4-Chloro-1H-pyrazol-1-yl)propanoic acid comprises a pyrazole ring substituted with a chlorine atom at the 4-position and a propanoic acid group attached at the 1-position of the pyrazole ring. The pyrazole moiety, a five-membered aromatic heterocycle containing two nitrogen atoms, is known for its stability and versatility in chemical reactions. The propanoic acid group introduces carboxylic acid functionality, which can participate in various biochemical interactions. This combination makes the compound a promising candidate for exploring its role in biological systems.

Recent studies have focused on the synthesis of 3-(4-Chloro-1H-pyrazol-1-yl)propanoic acid through efficient and scalable methods. Researchers have employed various strategies, including nucleophilic aromatic substitution and coupling reactions, to construct the molecule. One notable approach involves the reaction of 4-chloropyrazole with appropriate carboxylic acid derivatives under optimized conditions. These advancements have not only improved the yield but also reduced the production costs, making the compound more accessible for further research.

The biological activity of 3-(4-Chloro-1H-pyrazol-1-yl)propanoic acid has been a focal point of recent investigations. Studies have demonstrated its potential as an inhibitor of certain enzymes and receptors, which could be pivotal in treating various diseases. For instance, research has shown that this compound exhibits moderate inhibitory activity against kinases involved in cancer progression. Additionally, its ability to modulate ion channels suggests its potential role in neurodegenerative disorders.

In terms of pharmacokinetics, 3-(4-Chloro-1H-pyrazol-1-yl)propanoic acid has shown favorable absorption profiles in preclinical models. Its lipophilicity and solubility properties make it a suitable candidate for oral administration. However, further studies are required to evaluate its bioavailability and metabolic pathways in humans.

The application of computational chemistry tools has significantly enhanced our understanding of this compound's behavior at the molecular level. Molecular docking studies have revealed that 3-(4-Chloro-1H-pyrazol-1-yl)propanoic acid interacts effectively with target proteins through hydrogen bonding and hydrophobic interactions. These insights are invaluable for designing analogs with improved potency and selectivity.

In conclusion, 3-(4-Chloro-1H-pyrazol-1-yl)propanoic acid, with its unique structure and promising biological activities, represents a valuable addition to the arsenal of compounds being explored for therapeutic applications. As research continues to uncover its full potential, this compound holds the promise of contributing to innovative solutions in medicine and beyond.

• 180741-32-6(3-(4-chloro-3-methyl-1H-pyrazol-1-yl)propanoic acid)
• 1002033-70-6(methyl 3-(4-chloro-1H-pyrazol-1-yl)propanoate)
• 32089-46-6(2-(4-chloropyrazol-1-yl)acetic acid)
• 1006447-90-0(3-(4-Chloro-1H-pyrazol-1-yl)propylamine)
• 180741-47-3(3-(4-chloro-5-methyl-1H-pyrazol-1-yl)propanoic acid)
• 1006319-94-3(3-(4-Chloro-1H-pyrazol-1-yl)propan-1-ol)
• 1006319-31-8(4-(4-chloro-1H-pyrazol-1-yl)butanoic acid)
• 89532-73-0(3-pyrazol-1-ylpropanoic acid)
• 197094-12-5(2-Methyl-3-(1H-pyrazol-1-yl)propanoic acid)
• 957301-84-7(3-(4-chloro-1H-pyrazol-1-yl)-2-methylpropanoic acid)